media – Page 565 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Breakthrough status for Roche’s autism drug

Roche’s balovaptan has picked up a Breakthrough Therapy Designation in the US for its potential as a treatment for people with autism spectrum disorder (ASD), potentially placing the drug on a faster path to market.
- Source: pharmatimes
- 621
- February 5, 2018
ASD balovaptan New Approvals Roche
Ferring’s ZOMACTON® (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults

Administration (FDA) has approved ZOMACTON® (somatropin) for Injection 5 mg and 10 mg recombinant human growth hormone (GH) indicated for replacement of GH in adults with GH deficiency.
- Source: medindia.net
- 627
- February 5, 2018
FDA GH deficiency growth hormone ZOMACTON®
GSK China partners with Ali Health to launch innovative online service platform to improve adult vaccination consultation experience

GSK China and Ali Health jointly announced a strategic partnership to launch an innovative adult vaccination service system. The system will include online disease education and consultation, online HCP appointment booking, and deliver convenient online-to-offline (O2O) end-to-end service for users. Moreover, community healthcare service centres nationwide can utilise this platform to manage vaccination enquiries and requests. This will help enhance efficiency at the centres and help reduce costs and workload, thus optimising public healthcare institutions’s resources. By year-end, the platform is expected to cover 1500 community healthcare service centres in more than one hundred cities nationwide, including Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Nanjing and Wuhan.
- Source: gsk-china
- 574
- February 5, 2018
adult vaccination service system Ali Health GSK China health
Hospitals turn to mobile devices to cut costs, study shows

More than nine in 10 nurse managers see voice recognition and telehealth technologies intensifying over the next five years, while secure text messaging, voice communication and photographing wounds and skin conditions will be nearly universal. Major growth is expected in areas like remote patient monitoring.
- Source: Healthcare Dive
- 736
- February 5, 2018
digital health Market Views medical device
Wearable devices for business vs. fitness

Wearables, like smartwatches and fitness trackers, are popular with business professionals, and for good reason. The devices can collect data and provide insights, allowing wearers to track their fitness and productivity to reach their goals faster.
- Source: Tech Republic
- 688
- February 5, 2018
Internet of Things Market Views medical device wearables
The Future of Pharmacy

The interest in Blockchain and distributed ledger technology (DLT) has exploded in recent years with a large focus on the financial industry. Meanwhile, medical and pharmaceutical companies around the world are looking to DLT as a means of solving, securing, and streamlining their businesses. While there are many applications for DLT within the medical industry, one area where the technology excels is within supply chains.
- Source: Blockchain Healthcare Review
- 697
- February 5, 2018
blockchain Market Views pharmaceutical drugs
Preview — Global Pharmaceutical & Medical Device Exhibitions in February, 2018

Have you made your schedule for 2018? Take some time to consider your options and see what Ddu has planned this February!
- Source: Ddu
- 1,188
- February 2, 2018
Exhibitions & Activities medical device pharmaceutical
Final NHS nod for Janssen’s Imbruvica

Janssen’s Imbruvica will be routinely available on the NHS to treat certain patients with mantle cell lymphoma (MCL), after cost regulators issued a final green light for the drug.
- Source: Pharmatimes
- 530
- February 2, 2018
MCL New Approvals NHS
NHS plans to replace humans with AI technology in its 111 service

The NHS 111 service has begun to incorporate AI technology.
- Source: hospitalmanagement.net
- 621
- February 2, 2018
AI polices
NHS plans to be first to eliminate hepatitis C

NHS England has laid out plans for England to become the first country to eliminate hepatitis C, at least five years earlier than the World Health Organisation(WHO)’s target date of 2030.
- Source: pharmatimes
- 889
- February 2, 2018
hepatitis C NHS polices WHO

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.